Another study showed that TIM-3 mAbs injection slowed tumor progression in many mouse tumor models, such as MC38 colon carcinoma, WT3 sarcoma, CT26 colon adenocarcinoma, and TRAMP-C1 prostate tumor [65]. This evidence concerns the gene HAVCR2 and colon adenocarcinoma.